Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study
- PMID: 19823189
- PMCID: PMC2822093
- DOI: 10.1038/ijo.2009.195
Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study
Abstract
Type 2 diabetes is associated with obesity and is increasing at an alarming rate in youth. Although weight loss through lifestyle change is one of the primary treatment recommendations for adults with type 2 diabetes, the efficacy of this approach has not been tested with youth. This paper provides a summary of the reviews and meta-analyses of pediatric weight-loss interventions that informed the design and implementation of an intensive, family-based lifestyle weight management program for adolescents with type 2 diabetes and their families developed for the Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) study. A total of 1092 youth have been screened, and 704 families have been randomized for inclusion in this 15-center clinical trial sponsored by the National Institutes of Health. The TODAY study is designed to test three approaches (metformin, metformin plus rosiglitazone and metformin plus an intensive lifestyle intervention) to the treatment of a diverse cohort of youth, 10-17 years of age, within 2 years of their diagnosis. The principal goal of the TODAY Lifestyle Program (TLP) is to decrease baseline weight of youth by 7-10% (or the equivalent for children who are growing in height) through changes in eating and physical activity habits, and to sustain these changes through ongoing treatment contact. The TLP is implemented by interventionists called Personal Activity and Nutrition Leaders (PALs) and delivered to youth with type 2 diabetes, and at least one family support person. The TLP provides a model for taking a comprehensive, continuous care approach to the treatment of severe overweight in youth with comorbid medical conditions such as type 2 diabetes.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes.Pediatr Diabetes. 2007 Apr;8(2):74-87. doi: 10.1111/j.1399-5448.2007.00237.x. Pediatr Diabetes. 2007. PMID: 17448130 Free PMC article. Clinical Trial.
-
Youth-onset type 2 diabetes mellitus: lessons learned from the TODAY study.Mayo Clin Proc. 2014 Jun;89(6):806-16. doi: 10.1016/j.mayocp.2014.01.009. Epub 2014 Apr 3. Mayo Clin Proc. 2014. PMID: 24702733 Free PMC article. Clinical Trial.
-
Structure to utilize interventionists' implementation experiences of a family-based behavioral weight management program to enhance the dissemination of the standardized intervention: The TODAY study.Clin Trials. 2017 Aug;14(4):406-412. doi: 10.1177/1740774517707727. Epub 2017 May 9. Clin Trials. 2017. PMID: 28486851 Free PMC article. Clinical Trial.
-
Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2022 Sep 13;328(10):968-979. doi: 10.1001/jama.2022.7957. JAMA. 2022. PMID: 36098720
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
-
The future of treating youth-onset type 2 diabetes: focusing upstream and extending our influence into community environments.Curr Diab Rep. 2015 Mar;15(3):7. doi: 10.1007/s11892-015-0576-7. Curr Diab Rep. 2015. PMID: 25644815 Review.
-
Family behaviors and type 2 diabetes: What to target and how to address in interventions for adults with low socioeconomic status.Chronic Illn. 2016 Sep;12(3):199-215. doi: 10.1177/1742395316644303. Epub 2016 Apr 19. Chronic Illn. 2016. PMID: 27099387 Free PMC article.
-
Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience.Pediatr Obes. 2017 Aug;12(4):337-345. doi: 10.1111/ijpo.12148. Epub 2016 May 10. Pediatr Obes. 2017. PMID: 27161901 Free PMC article. Clinical Trial.
-
Safety and tolerability of the treatment of youth-onset type 2 diabetes: the TODAY experience.Diabetes Care. 2013 Jun;36(6):1765-71. doi: 10.2337/dc12-2390. Diabetes Care. 2013. PMID: 23704676 Free PMC article. Clinical Trial.
-
High anxiety and depressive symptoms in partners of type 1 diabetes persons in a sample of the Brazilian population.Diabetol Metab Syndr. 2020 Mar 24;12:23. doi: 10.1186/s13098-020-00531-5. eCollection 2020. Diabetol Metab Syndr. 2020. PMID: 32211074 Free PMC article.
References
-
- Kaufman F. Type 2 diabetes mellitus in children and youth: a new epidemic. J Pediatr Endocrinol Metab. 2002;15:737–744. - PubMed
-
- Kaufman F. Type 2 diabetes in youth: rates, antecedents, treatment, problems and prevention. Pediatr Diabetes. 2007;8:4–6. - PubMed
-
- Pinhas-Hamiel O, Zeitler P. Clinical presentation and treatment of type 2 diabetes. Pediatr Diabetes. 2007;8:16–27. - PubMed
-
- Shaw J. Epidemiology of childhood type 2 diabets and obesity. Pediatr Diabetes. 2007;8 Suppl 9:7–15. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 DK061254/DK/NIDDK NIH HHS/United States
- U01-DK61239/DK/NIDDK NIH HHS/United States
- U01 DK061242/DK/NIDDK NIH HHS/United States
- U01-DK61230/DK/NIDDK NIH HHS/United States
- U01 DK061212/DK/NIDDK NIH HHS/United States
- M01 RR014467/RR/NCRR NIH HHS/United States
- U01 DK061230/DK/NIDDK NIH HHS/United States
- M01-RR00036/RR/NCRR NIH HHS/United States
- M01 RR000043/RR/NCRR NIH HHS/United States
- M01 RR000084/RR/NCRR NIH HHS/United States
- M01-RR00043-45/RR/NCRR NIH HHS/United States
- M01-RR00125/RR/NCRR NIH HHS/United States
- U01-DK61242/DK/NIDDK NIH HHS/United States
- M01 RR000069/RR/NCRR NIH HHS/United States
- U01-DK61254/DK/NIDDK NIH HHS/United States
- K24 MH070446/MH/NIMH NIH HHS/United States
- M01 RR000036/RR/NCRR NIH HHS/United States
- U01-DK61212/DK/NIDDK NIH HHS/United States
- 1K24MH070446-01/MH/NIMH NIH HHS/United States
- M01-RR01066/RR/NCRR NIH HHS/United States
- M01 RR001066/RR/NCRR NIH HHS/United States
- M01-RR00069/RR/NCRR NIH HHS/United States
- M01-RR14467/RR/NCRR NIH HHS/United States
- M01 RR000125/RR/NCRR NIH HHS/United States
- U01 DK061239/DK/NIDDK NIH HHS/United States
- M01-RR00084/RR/NCRR NIH HHS/United States